References
- 1Urowitz MB, Gladman DD, Tom BD, Ibanez D, Farewell VT. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus. J Rheumatol. 2008; 35:2152-8.1879300410.3899/jrheum.080214UrowitzMBGladmanDDTomBDIbanezDFarewellVTChanging patterns in mortality and disease outcomes for patients with systemic lupus erythematosusJ Rheumatol20083521528
- 2Urowitz MB, Gladman D, Ibanez D, Fortin P, Sanchez-Guerrero J, Bae S, et al. Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort. Lupus. 2007; 16:731-5.10.1177/096120330708111317728367UrowitzMBGladmanDIbanezDFortinPSanchez-GuerreroJBaeSet alClinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohortLupus2007167315
- 3Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jr., Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997; 145:408-15.10.1093/oxfordjournals.aje.a0091229048514ManziSMeilahnENRairieJEConteCGMedsgerTA
Jr Jansen-McWilliamsLet alAge-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham StudyAm J Epidemiol199714540815 - 4Barsalou J, Bradley TJ, Silverman ED. Cardiovascular risk in pediatric-onset rheumatological diseases. Arthritis Res Ther. 2013; 15:212.23731870BarsalouJBradleyTJSilvermanEDCardiovascular risk in pediatric-onset rheumatological diseasesArthritis Res Ther201315212
- 5Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2009; 61:13-20.19116979HershAOvonScheven EYazdanyJPanopalisPTrupinLJulianLet alDifferences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosusArthritis Rheum2009611320
- 6Gustafsson JT, Svenungsson E. Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus. Autoimmunity. 2014; 47:67-76.10.3109/08916934.2013.85600524228980GustafssonJTSvenungssonEDefinitions of and contributions to cardiovascular disease in systemic lupus erythematosusAutoimmunity2014476776
- 7Sozeri B, Deveci M, Dincel N, Mir S. The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol. 2013; 28:471-6.10.1007/s00467-012-2342-223135607SozeriBDeveciMDincelNMirSThe early cardiovascular changes in pediatric patients with systemic lupus erythematosusPediatr Nephrol2013284716
- 8Huang YL, Chung HT, Chang CJ, Yeh KW, Chen LC, Huang JL. Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2009; 60:3766-75.10.1002/art.2501919950269HuangYLChungHTChangCJYehKWChenLCHuangJLLymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosusArthritis Rheum200960376675
- 9Falaschi F, Ravelli A, Martignoni A, Migliavacca D, Sartori M, Pistorio A, et al. Nephrotic-range proteinuria: the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum. 2000; 43:1405-9.1085780110.1002/1529-0131(200006)43:6<;1405::AID-ANR26>3.0.CO;2-VFalaschiFRavelliAMartignoniAMigliavaccaDSartoriMPistorioAet alNephrotic-range proteinuria: the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosusArthritis Rheum20004314059
- 10Bhatt SP, Handa R, Gulati GS, Sharma S, Pandey RM, Aggarwal P, et al. Peripheral vascular disease in systemic lupus erythematosus. Lupus. 2007; 16:720-3.1772836510.1177/0961203307081123BhattSPHandaRGulatiGSSharmaSPandeyRMAggarwalPet alPeripheral vascular disease in systemic lupus erythematosusLupus2007167203
- 11Canpolat N, Kasapcopur O, Caliskan S, Gokalp S, Bor M, Tasdemir M, et al. Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. Pediatr Nephrol. 2013; 28:305-13.2305265410.1007/s00467-012-2317-3CanpolatNKasapcopurOCaliskanSGokalpSBorMTasdemirMet alAmbulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosusPediatr Nephrol20132830513
- 12Ortiz TT, Terreri MT, Caetano M, Souza FS, D’Almeida V, Sarni RO, et al. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations. Ann Nutr Metab. 2013; 63:77-82.10.1159/00035107623942034OrtizTTTerreriMTCaetanoMSouzaFSD’AlmeidaVSarniROet alDyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrationsAnn Nutr Metab2013637782
- 13Boros CA, Bradley TJ, Cheung MM, Bargman JM, Russell JL, McCrindle BW, et al. Early determinants of atherosclerosis in paediatric systemic lupus erythematosus. Clin Exp Rheumatol. 2011; 29:575-81.21640055BorosCABradleyTJCheungMMBargmanJMRussellJLMcCrindleBWet alEarly determinants of atherosclerosis in paediatric systemic lupus erythematosusClin Exp Rheumatol20112957581
- 14Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR, Jr., Tudor-Locke C, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011; 43:1575-81.10.1249/MSS.0b013e31821ece1221681120AinsworthBEHaskellWLHerrmannSDMeckesNBassettDR
Jr Tudor-LockeCet al2011 Compendium of physical activities: a second update of codes and MET valuesMed Sci Sports Exerc201143157581 - 15Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000; 32:S498-504.1099342010.1097/00005768-200009001-00009AinsworthBEHaskellWLWhittMCIrwinMLSwartzAMStrathSJet alCompendium of physical activities: an update of activity codes and MET intensitiesMed Sci Sports Exerc200032S498504
- 16Boucelma M, Haddoum F, Chaudet H, Kaplanski G, Mazouni-Brahimi N, Rezig-Ladjouze A, et al. Cardiovascular risk and lupus disease. Int Angiol. 2011; 30:18-24.21248669BoucelmaMHaddoumFChaudetHKaplanskiGMazouni-BrahimiNRezig-LadjouzeAet alCardiovascular risk and lupus diseaseInt Angiol2011301824
- 17Telles RW, Lanna CC, Sousa AJ, Navarro TP, Souza FL, Rodrigues LA, et al. Progression of carotid atherosclerosis in patients with systemic lupus erythematosus. Clin Rheumatol. 2013; 32:1293-300.10.1007/s10067-013-2264-923620348TellesRWLannaCCSousaAJNavarroTPSouzaFLRodriguesLAet alProgression of carotid atherosclerosis in patients with systemic lupus erythematosusClin Rheumatol2013321293300
- 18Parker B, Bruce IN. The metabolic syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am. 2010; 36:81-97.10.1016/j.rdc.2009.12.00420202592ParkerBBruceINThe metabolic syndrome in systemic lupus erythematosusRheum Dis Clin North Am2010368197
- 19Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014; 5:927-46.25489440Rafieian-KopaeiMSetorkiMDoudiMBaradaranANasriHAtherosclerosis: process, indicators, risk factors and new hopesInt J Prev Med2014592746
- 20Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012; 34:290-6.TouboulPJHennericiMGMeairsSAdamsHAmarencoPBornsteinNet alMannheim carotid intima-media thickness and plaque consensus (2004-2006-2011)An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis2012342906
- 21Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, et al. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009; 60: 1496-507.1940495310.1002/art.24469SchanbergLESandborgCBarnhartHXArdoinSPYowEEvansGWet alPremature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohortArthritis Rheum2009601496507
- 22Bowser CS, Kumar S, Salciccioli L, Kutlin A, Lazar J, Rahim I, et al. Absence of Chlamydia pneumoniae and signs of atherosclerotic cardiovascular disease in adolescents with systemic lupus erythematosus. Pediatr Cardiol. 2008; 29:545-51.10.1007/s00246-007-9131-x18080155BowserCSKumarSSalciccioliLKutlinALazarJRahimIet alAbsence of Chlamydia pneumoniae and signs of atherosclerotic cardiovascular disease in adolescents with systemic lupus erythematosusPediatr Cardiol20082954551
- 23Engelen L, Ferreira I, Stehouwer CD, Boutouyrie P, Laurent S. Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors. Eur Heart J. 2013; 34:2368-80.2318680810.1093/eurheartj/ehs380EngelenLFerreiraIStehouwerCDBoutouyriePLaurentSReference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factorsEur Heart J201334236880
- 24de Leeuw K, Smit AJ, de Groot E, van Roon AM, Kallenberg C G, Bijl M. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis. 2009; 206:546-50.1938967410.1016/j.atherosclerosis.2009.03.018de LeeuwKSmitAJde GrootEvan RoonAMKallenbergC GBijlMLongitudinal study on premature atherosclerosis in patients with systemic lupus erythematosusAtherosclerosis200920654650
- 25Viazzi F, Pontremoli R. Blood pressure, albuminuria and renal dysfunction: the ‘chicken or egg’ dilemma. Nephrol Dial Transplant. 2014; 29:1453-5.10.1093/ndt/gfu18324811230ViazziFPontremoliRBlood pressure, albuminuria and renal dysfunction: the ‘chicken or egg’ dilemmaNephrol Dial Transplant20142914535
- 26Tongma C, Shikuma CM, Nakamoto BK, Kallianpur KJ, Umaki TM, Barbour JD, et al. Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy. Hawaii J Med Public Health. 2013; 72:34-8.24052917TongmaCShikumaCMNakamotoBKKallianpurKJUmakiTMBarbourJDet alAlbuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapyHawaii J Med Public Health201372348
- 27Ma H, Lin H, Hofman A, Hu Y, Li X, He W, et al. Low-grade albuminuria is associated with carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults: the Shanghai Changfeng Study. Atherosclerosis. 2013; 228:237-42.2345335110.1016/j.atherosclerosis.2013.02.007MaHLinHHofmanAHuYLiXHeWet alLow-grade albuminuria is associated with carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults: the Shanghai Changfeng StudyAtherosclerosis201322823742
- 28Yang L, Tao J, Tang X, Wang Y, He X, Xu G, et al. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients. J Eur Acad Dermatol Venereol. 2012; 26:95-101.2185142410.1111/j.1468-3083.2011.04211.xYangLTaoJTangXWangYHeXXuGet alPrevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patientsJ Eur Acad Dermatol Venereol20122695101
- 29Iaccarino L, Bettio S, Zen M, Nalotto L, Gatto M, Ramonda R, et al. Premature coronary heart disease in SLE: can we prevent progression? Lupus. 2013; 22: 1232-42.10.1177/096120331349287124097995IaccarinoLBettioSZenMNalottoLGattoMRamondaRet alPremature coronary heart disease in SLE: can we prevent progression?Lupus201322123242
- 30Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012; 71:1771-82.2285146910.1136/annrheumdis-2012-201940BertsiasGKTektonidouMAmouraZAringerMBajemaIBerdenJHet alJoint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritisAnn Rheum Dis201271177182
- 31Kockx M, Jessup W, Kritharides L. Cyclosporin A and atherosclerosis – cellular pathways in atherogenesis. Pharmacol Ther. 2010; 128:106-18.10.1016/j.pharmthera.2010.06.00120598751KockxMJessupWKritharidesLCyclosporin A and atherosclerosis – cellular pathways in atherogenesisPharmacol Ther201012810618
- 32Sazliyana S, Mohd Shahrir MS, Kong CT, Tan HJ, Hamidon BB, Azmi MT. Implications of immuno-suppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients. Lupus. 2011; 20:1260-6.10.1177/0961203311411347SazliyanaSMohd ShahrirMSKongCTTanHJHamidonBBAzmiMTImplications of immuno-suppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patientsLupus20112012606
- 33Oryoji K, Kiyohara C, Horiuchi T, Tsukamoto H, Niiro H, Shimoda T, et al. Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with A. Mod Rheumatol. 2014; 24:86-92.2426176310.3109/14397595.2013.852838OryojiKKiyoharaCHoriuchiTTsukamotoHNiiroHShimodaTet alReduced carotid intima-media thickness in systemic lupus erythematosus patients treated with AMod Rheumatol2014248692